| |
Ahto Obama Administration Offers Supreme Court Robust Defense Of Health Law
Men With Advanced Prostate Cancer Should Be Tested For Genetic Mutations, Study FindsThe recommendation is a major stanley mug shift from previous thinking in which only men with a family history of prostate cancer were urg stanley water bottle ed to consider testing. Currently insurers are unlikely to cover it in any other case. Meanwhile, a new test could help those men with advanced prostate cancer decide what treatment is best for them, and a high-priced drug for the disease is at the center of a takeover battle. The Washington Post:Leading Researchers Recommend Major Change In Prostate Cancer TreatmentLeading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations -- both to help steer their treatment and to alert family members who themselves might be at increased risk for a stanley thermoskanne range of cancers. This new recommendation, which represents a major change in approach, was prompted by a study published Wednesday in the New England Journal of Medicine. The researchers found that almost 12 percent of men with advanced cancer had defects in genes that are designed to fix damage to DNA, compared to 4.6 percent of patients with disease that hadn t spread. McGinley, 7/6 The Wall Street Journal:Test Aids Prostate Cancer TreatmentGenomic Health Inc. has struck a deal to commercialize a new blood test that can help advanced prostate cancer patients decide whether to try costly new-generation drugs or rely on much chea Brlx Also In Global Health News: Zimbabwe s HIV Prevalence Declines; Sri Lanka Flooding; Online Tool To Track Outbreaks; U.S. Recognition Of S. Sudan; TB In Swaziland
Thursday, Jun 11 2009Legislation Would Give 12 Years of Market Exclusivity to Brand-Name Biologic Drug ManufacturersRep. Anna Eshoo D-Calif. , House Energy and Commerce Committee ranking member Joe Barton R-Texas and Rep. Jay Inslee D-Wash. on Tuesday introduced legislation that would allow FDA to approve generic versions of biologic drugs, CongressDaily reports. The bill would give brand-name biologic drugmakers a 12-year period of exclusiv owala website ity for their products before generic competition can be introduced. The measure also would require data from generic companies.The legislation competes with a bill HR 1427 introduced last week by Energy and Commerce Committee Chair Henry Waxman D-Calif. and Health Subcommittee ranking member Nathan Deal R-Ga. that would give brand-name companies five years of exclusivity and provide FDA with more flexibility in determining data required for generic approval CongressDaily, 3/18 . This is part of the Morning Briefing, a summary of health policy cov stanley canada erage from major n owala ews organizations.Sign up for an email subscription.Recent Morning BriefingsToday, November 20Wednesday, November 19Tuesday, November 18Monday, November 17Friday, November 14Thursday, November 13MoreRSSWe want to hear from you: Contact UsMore From KFF Health NewsComplaints About Gaps in Medicare Advantage Networks Are Common. Federal Enforcement Is Rare.Waning Immunity and Falling Vaccination Rates Fuel Pertussis OutbreaksA Small Texas Think Tank Cultivated Covid Diss
|
|
- 26/1/13(火) 1:27 -
